Anocca signs licensing deal for EmendoBio’s gene-editing tech
Pharmaceutical Technology
MARCH 15, 2024
Anocca has entered a licensing agreement with EmendoBio for the use of the latter’s OMNI-A4 nuclease, a gene editing technology.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
MARCH 15, 2024
Anocca has entered a licensing agreement with EmendoBio for the use of the latter’s OMNI-A4 nuclease, a gene editing technology.
Pharmaceutical Technology
APRIL 26, 2024
Regeneron Pharmaceuticals has collaborated with Mammoth Biosciences to develop in vivo clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 17, 2024
The US FDA has approved Vertex's CASGEVY, a gene-edited cell therapy, to treat transfusion-dependent beta thalassemia.
Pharmaceutical Technology
JUNE 29, 2023
Experts warn caution around CRISPR gene editing technology on human embryos as it may have dangerous consequences.
Pharmaceutical Technology
FEBRUARY 23, 2023
Moderna has entered a strategic research and development partnership with ElevateBio’s Life Edit Therapeutics to discover and develop new in-vivo mRNA gene editing therapies. The post Moderna partners with Life Edit for mRNA gene editing therapies appeared first on Pharmaceutical Technology.
Drug Discovery World
FEBRUARY 22, 2024
Following the first regulatory approval of a CRISPR-based drug in late 2023, over ten years since the CRISPR-Cas9 system was elucidated, there is considerable optimism about the future potential for gene editing technologies. appeared first on Drug Discovery World (DDW).
STAT News
FEBRUARY 22, 2023
Moderna is aiming to build a gene editing franchise powered by some of the same technologies used in its COVID-19 vaccines. The Cambridge biotech company announced Wednesday that it will partner with Life Edit Therapeutics to develop potentially permanent treatments for rare genetic diseases and other conditions.
Drug Discovery World
DECEMBER 6, 2023
Gene editing company Eligo Bioscience has announced a successful $30 million Series B funding round, led by Sanofi Ventures. “We By focusing on the in-vivo delivery of genetic cargoes to the microbiome, Eligo’s hopes to go beyond traditional gene therapy and gene editing.
STAT News
SEPTEMBER 21, 2022
The short history of CRISPR gene editing in humans has, with rare exception, been a history of triumphant progress: A patient apparently cured of sickle cell in 2019, six patients with toxic DNA knocked out of their liver last year, another six patients with a different strand of toxic liver DNA knocked out last week.
STAT News
NOVEMBER 14, 2022
Ionis will pay the Bay Area gene-editing startup $80 million upfront as the companies work together to develop up to four gene-editing therapies, with the option to add four more targets. On Monday, the company announced a partnership with Metagenomi to kickstart these efforts.
Drug Discovery World
NOVEMBER 30, 2023
Scientists have used CRISPR gene editing to target and rapidly destroy glioblastoma cells in an approach that could apply to other highly mutated cancers. The post CRISPR gene editing ‘cancer shredding’ technique destroys brain tumours appeared first on Drug Discovery World (DDW).
STAT News
NOVEMBER 7, 2022
Verve Therapeutics said Monday that its experimental gene-editing treatment for a common form of heart disease was placed on clinical hold by the Food and Drug Administration, potentially delaying an ongoing, early-stage clinical trial. The Cambridge, Mass.-based
Pharmaceutical Technology
JANUARY 10, 2024
Vertex Pharmaceuticals has announced the approval of CASGEVY (exagamglogene autotemcel [exa-cel]), the first CRISPR/Cas9 gene-edited therapy.
BioTech 365
FEBRUARY 23, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers invent new gene-editing tool.Researchers from the University of Illinois Chicago have discovered a new gene-editing technique that allows for the programming of sequential cuts—or edits—over time.
Drug Discovery World
OCTOBER 11, 2022
A team of researchers at Northwestern University in the US has devised a new platform for gene editing that could inform the future application of CRISPR-based therapeutics. They created a system to deliver the cargo required for generating the gene editing machine known as CRISPR-Cas9. Builds on a 25-year effort.
BioTech 365
NOVEMBER 25, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientists produce new antibiotics by gene editing.Scientists have discovered a new route to produce complex antibiotics exploiting gene editing to re-program pathways to future medicines urgently required … Continue reading (..)
Bio Pharma Dive
FEBRUARY 8, 2022
Shares of the gene editing biotech slumped Tuesday on news that chief medical officer Lisa Michaels had joined a growing list of executive departures.
Pharmaceutical Technology
DECEMBER 14, 2023
The payment, which encompasses newly approved Casgevy, is the latest deal in a long line of CRISPR licensing twists and turns.
BioTech 365
SEPTEMBER 29, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: UK permits development of gene-edited crops in climate fight.Britain’s government plans to allow researchers to use gene-editing techniques to develop crops that can increase yields, reduce the … Continue reading → (..)
BioTech 365
OCTOBER 1, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: UK clears the way for gene-edited crops. from European Biotechnology – first and foremost in European biotech [link].
BioTech 365
NOVEMBER 12, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New gene-edited barley that could improve beer.After a spell of unexpected rain, before the harvest season, a farmer may be faced with the unpredictable problem of untimely … Continue reading →
pharmaphorum
SEPTEMBER 28, 2022
Vertex Pharma and partner CRISPR Therapeutics will start a rolling marketing application in the US for their gene-editing drug for sickle cell disease (SCD) and beta thalassaemia later this year. The time places exa-cel in pole position to become the first drug developed based on CRISPR/Cas9 gene-editing technology to reach the market.
BioTech 365
MARCH 30, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Prime editing enables precise gene editing without collateral damage.The latest gene editing technology, prime editing, expands the ‘genetic toolbox’ for more precisely creating disease models and correcting … (..)
BioTech 365
DECEMBER 9, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New biosensors shine a light on CRISPR gene editing.Detecting the activity of CRISPR gene editing tools in organisms with the naked eye and an ultraviolet flashlight is … Continue reading →
BioTech 365
JULY 12, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: WHO details steps to ensure human gene editing is safe, ethical.The World Health Organization published a slew of recommendations Monday on how to ensure gene editing research … Continue reading →
BioTech 365
NOVEMBER 2, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Moderna finally cracks into gene editing with Metagenomi pact thanks to ‘irresistible’ data.Moderna finally cracks into gene editing with Metagenomi pact thanks to ‘irresistible’ data aarmstrong Mon, … (..)
BioTech 365
AUGUST 23, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene editing could render mosquitos infertile, reducing disease spread.Mosquitos spread viruses that cause potentially deadly diseases such as Zika, dengue fever and yellow fever.
BioTech 365
JANUARY 10, 2022
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: JPM 2022: Pfizer re-ups gene editing interest with $300M Beam pact, $1.35B in biobucks.JPM 2022: Pfizer re-ups gene editing interest with $300M Beam pact, $1.35B in biobucks … Continue reading →
BioTech 365
OCTOBER 20, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New tool offers ways to improve CRISPR gene-editing method.The ability to edit the genome by altering the DNA sequence inside a living cell is powerful for research … Continue reading →
BioTech 365
OCTOBER 20, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools.Princeton and MIT gene-editing pioneers uncover clues for improving CRISPR and other tools aliu Wed, … Continue reading →
pharmaphorum
JUNE 12, 2022
A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has continued to show impressive results in clinical trial, with an update at the EHA congress showing long-term effects on the symptoms of both beta thalassaemia and sickle cell disease. billion product if it gets approved for both indications.
BioTech 365
NOVEMBER 12, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Bayer powers gene-editing startup Metagenomi to $65M A round.Bayer powers gene-editing startup Metagenomi to $65M A round ntaylor Thu, 11/12/2020 – 08:03 from FierceBiotech: Biotech [link].
BioTech 365
NOVEMBER 9, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene editing study finds gene for heat tolerance in corals.An
BioTech 365
DECEMBER 1, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genomics, gene-editing and the Blue Revolution.Aquaculture—the farming of fish and shellfish, is the world’s fastest growing primary industry.
Pharmaceutical Technology
AUGUST 14, 2023
HebeCell has forged a strategic collaboration with Logomix for researching and developing gene-edited natural killer cells (NK cells).
BioTech 365
JULY 5, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Russia’s first cloned calf opens door to gene-edited cattle.Researchers from Ernst Federal Science Center for Animal Husbandry, Skoltech, Moscow State University and their colleagues have produced the … Continue reading (..)
BioTech 365
DECEMBER 4, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Advancing gene editing with new CRISPR/Cas9 variant.Using a new variant to repair DNA will improve both safety and effectiveness of the much-touted CRISPR-Cas9 tool in genetic research, … Continue reading →
BioTech 365
NOVEMBER 19, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers recommend more transparency for gene-edited crops.Researchers at North Carolina State University call for a coalition of biotech industry, government and non-government organizations, trade organizations, and academic (..)
BioTech 365
OCTOBER 25, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report.Intellia, LogicBio fuel hope for in vivo gene editing with new … Continue reading →
BioTech 365
SEPTEMBER 17, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Research shows potential of gene editing in barley.An
BioTech 365
FEBRUARY 19, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Precision’s one-time gene editing treatment lowers cholesterol in monkeys for 3 years.Precision’s one-time gene editing treatment lowers cholesterol in monkeys for 3 years arlene.weintraub Fri, 02/19/2021 – … (..)
BioTech 365
JANUARY 28, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: TALEN gene editing tool more efficient than CRISPR-Cas9 in compact DNA: study.TALEN gene editing tool more efficient than CRISPR-Cas9 in compact DNA: study aliu Thu, 01/28/2021 – … Continue reading →
BioTech 365
SEPTEMBER 14, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene-edited livestock ‘surrogate sires’ successfully made fertile.For the first time, scientists have created pigs, goats and cattle that can serve as viable “surrogate sires,” male animals that … (..)
BioTech 365
MAY 10, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Researchers analyze consumer preferences for gene edits in the fruit industry.In states such as California and Florida, the $3 billion orange and citrus industry is big business.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content